ProCE Banner Activity

PTCL Management: Expert Responses to Frequently Asked Questions

Clinical Thought
Expert responses to clinical questions on treatment challenges in peripheral T-cell lymphomas asked by clinicians at a recent CCO symposium on PTCL.

Released: February 07, 2020

Expiration: February 05, 2021

No longer available for credit.

Share

Faculty

Steven M. Horwitz

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Seagen

Takeda Oncology

Faculty Disclosure

Primary Author

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York

Steven M. Horwitz, MD, has disclosed that he has received consulting fees from Affirmed, Astex, Celgene, Kyowa Hakko Kirin, Merck, Seattle Genetics, Takeda, and Verastem and funds for research support from ADC Therapeutics, Celgene, Corvus, Daiichi Sankyo, Forty Seven, Kyowa Hakko Kirin, Portola, Seattle Genetics, Takeda, Trillium, and Verastem.